Literature DB >> 8248228

Newly expressed progesterone receptor cannot activate stable, replicated mouse mammary tumor virus templates but acquires transactivation potential upon continuous expression.

C L Smith1, T K Archer, G Hamlin-Green, G L Hager.   

Abstract

During development and differentiation, the expression of transcription factors is regulated in a temporal fashion. Newly expressed transcription factors must interact productively with target genes organized in chromatin. Although the mechanisms governing factor binding to chromatin templates are not well understood, it is now clear that template access can be dramatically influenced by nucleoprotein structure. We have examined the ability of a well characterized transactivator, the progesterone receptor (PR), to activate the mouse mammary tumor virus (MMTV) promoter organized either in stable, replicating templates that have a highly ordered nucleosome structure or as transiently transfected DNA, which adopts a less-defined structure. If the PR is transiently expressed in cells harboring both replicated and transient MMTV receptor constructs, it cannot significantly activate the stable replicated MMTV template. In contrast, when PR cDNA is stably inserted into the same cells and constitutively expressed, it gains the ability to activate both chromosomal and transiently introduced templates. These results demonstrate that newly expressed PR is not competent to activate the MMTV template in its native nucleoprotein conformation but acquires this ability upon prolonged expression in replicating cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248228      PMCID: PMC47950          DOI: 10.1073/pnas.90.23.11202

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Threshold phenomena and long-distance activation of transcription by RNA polymerase II.

Authors:  P J Laybourn; J T Kadonaga
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

2.  Glucocorticoid and progesterone receptors bind to the same sites in two hormonally regulated promoters.

Authors:  D von der Ahe; S Janich; C Scheidereit; R Renkawitz; G Schütz; M Beato
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

3.  Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element.

Authors:  K S Zaret; K R Yamamoto
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells.

Authors:  W J King; G L Greene
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

5.  Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo.

Authors:  M G Cordingley; A T Riegel; G L Hager
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

6.  Apolipoprotein C-II mRNA levels in primate liver. Induction by estrogen in the human hepatocarcinoma cell line, HepG2.

Authors:  T K Archer; S P Tam; K V Deugau; R G Deeley
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

7.  Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation.

Authors:  T K Archer; P Lefebvre; R G Wolford; G L Hager
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

8.  Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors.

Authors:  S K Yoshinaga; C L Peterson; I Herskowitz; K R Yamamoto
Journal:  Science       Date:  1992-12-04       Impact factor: 47.728

9.  The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction.

Authors:  A C Cato; R Miksicek; G Schütz; J Arnemann; M Beato
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

10.  Removal of positioned nucleosomes from the yeast PHO5 promoter upon PHO5 induction releases additional upstream activating DNA elements.

Authors:  A Almer; H Rudolph; A Hinnen; W Hörz
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  8 in total

Review 1.  Chromatin remodeling during glucocorticoid receptor regulated transactivation.

Authors:  Heather A King; Kevin W Trotter; Trevor K Archer
Journal:  Biochim Biophys Acta       Date:  2012-03-06

2.  Antiprogestins prevent progesterone receptor binding to hormone responsive elements in vivo.

Authors:  M Truss; J Bartsch; M Beato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

3.  A functional cyclic AMP response element plays a crucial role in neuroendocrine cell type-specific expression of the secretory granule protein chromogranin A.

Authors:  H Wu; S K Mahata; M Mahata; N J Webster; R J Parmer; D T O'Connor
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway.

Authors:  W D Pennie; G L Hager; C L Smith
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

5.  A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2.

Authors:  Angeliki Magklara; Catharine L Smith
Journal:  Mol Endocrinol       Date:  2008-11-26

6.  Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.

Authors:  J S Mymryk; D Berard; G L Hager; T K Archer
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  Immunolocalization of estrogen receptor protein in the mouse blastocyst during normal and delayed implantation.

Authors:  Q Hou; B C Paria; C Mui; S K Dey; J Gorski
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

8.  Glucocorticoids and protein kinase A coordinately modulate transcription factor recruitment at a glucocorticoid-responsive unit.

Authors:  M L Espinás; J Roux; R Pictet; T Grange
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.